Abstract
Parthenogenesis is a naturally occurring process where an oocyte is activated without sperm contribution. In mammals, parthenogenetic (PG) embryos cannot develop to term. The most commonly used method of artificially making diploid PG embryos is using via chemical activation of the egg and by preventing extrusion of the second polar body. Parthenogenetic embryonic stem (PGES) cells are derived from the inner cell mass of PG embryo at the blastocyst stage. They are pluripotent, i.e., they can differentiate into all three germ layers: ecto-, meso-, and endoderm, and can be propagated as stem cells in culture for prolonged periods of time. PGES cells offer an easily obtainable pool of stem cells that can be used as a source for derivation of autologous tissues, albeit limited to females in reproductive age. PGES cells derivation does not require destruction of a viable embryo and therefore bypasses the ethical debates surrounding the use of naturally fertilized embryos. Nonhuman primates are the closest species to human in the tree of evolution and therefore are excellent models for studying human development and diseases. PGES cells from nonhuman primate and human parthenogenetically activated oocyte have recently been derived (1–3). These cells offer a valuable tool for studying the developmental, differentiation, and functional potential of the PGES cells in the context of their clinical application in organ and tissue transplantations in humans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Matsuda T, Wake N. Genetics and molecular markers in gestational trophoblastic disease with special reference to their clinical application. Best Pract Res Clin Obstet Gynaecol 2003;17:827–36.
Mutter GL. Role of imprinting in abnormal human development. Mutat Res 1997;396:141–7.
Surti U, Hoffner L, Chakravarti A, Ferrell RE. Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin. Am J Hum Genet 1990;47:635–43.
Mai Q, Yu Y, Li T, et al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res 2007;17:1008–19.
Revazova ES, Turovts NA, Kochetkova OD, et al HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2008 10:11–24.
Revazova ES, Turovts NA, Kochetkova OD, et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2007;9:432–49.
Strain L, Warner JP, Johnston T, Bonthron DT. A human parthenogenetic chimaera. Nat Genet 1995;11:164–9.
Surani MA. Parthenogenesis in man. Nat Genet 1995;11:111–3.
Mitalipov SM, Nusser KD, Wolf DP. Parthenogenetic activation of rhesus monkey oocytes and reconstructed embryos. Biol Reprod 2001;65:253–9.
Sotomaru Y, Katsusava Y, Hatada I, Obata Y, Sasaki H, Kono T. Unregulated expression of the imprinted genes H19 and Igf2r in mouse uniparental fetuses. J Biol Chem 2002;277:12474–8.
Ogawa H, Wu Q, Komiyama J, et al Disruption of parental-specific expression of imprinted genes in uniparental fetuses. FEBS Lett 2006;580;5377–84.
Lyle R. Gametic imprinting in development and disease. J Endocrinol 1997;155:1–12.
Zvetkova I, Apedaile A, Ramsahoye B, et al. Global hypomethylation of the genome in XX embryonic stem cells. Nat Genet 2005;37:1274–9.
Wobus AM, Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 2005;85:635–78.
Cibelli JB, Grant KA, Pahapman KB, et al. Parthenogenetic stem cells in nonhuman primates. Science 2002;295:819.
Vrana KE, Hipp JD, Goss AM, et al. Nonhuman primate parthenogenetic stem cells. Proc Natl Acad Sci U S A 2003;100 Suppl 1:11911–6.
Sanchez-Pernaute, R, Stder L, Ferrari D, et al Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno-1) after transplantation. Stem Cells 2005;23:914–22.
Ferrari D, Sanchez-Pernaute R, Lee H, Studer L, Isacson O. Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. Eur J Neurosci 2006;24:1885–96.
Dighe V, Clepper L, Pedersen D, et al. Heterozygous embryonic stem cell lines derived from nonhuman primate parthenotes. Stem Cells 2008;26:756–66.
Cheng L. More new lines of human parthenogenetic embryonic stem cells. Cell Res 2008;18:215–7.
Sapienza C. Parental imprinting of genes. Sci Am 1990;263:52–60.
Tang Wy, Ho SM. Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord 2007;8:173–82.
Swales AK, Spears N. Genomic imprinting and reproduction. Reproduction 2005;130:389–99.
Fujimoto A, Mitalipov SM, Kuo HC, Wolf DP. Aberrant genomic imprinting in rhesus monkey embryonic stem cells. Stem Cells 2006;24:595–603.
Newman-Smith ED, Werb Z. Stem cell defects in parthenogenetic peri-implantation embryos. Development 1995;121:2069–77.
Horii T, Kimura M, Morita S, Nagao Y, Hatada I. Loss of genomic imprinting in mouse parthenogenetic embryonic stem cells. Stem Cells 2008;26:79–88.
Kono T, Obata Y, Wu Q, et al. Birth of parthenogenetic mice that can develop to adulthood. Nature 2004;428:860–4.
Kono T, Sotomaru Y, Katsuzawa Y, Dandolo L. Mouse parthenogenetic embryos with monoallelic H19 expression can develop to day 17.5 of gestation. Dev Biol 2002;243;294–300.
Mitalipov S, Clepper L, Sritanaudomchai H, Fujimoto A, Wolf D. Methylation status of imprinting centers for H19/IGF2 and SNURF/SNRPN in primate embryonic stem cells. Stem Cells 2007;25:581–8.
Runte M, Kroisel PM, Gillessen-Kaesbach G, et al. SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome. Hum Genet 2004;114:553–61.
Reik W, Maher ER. Imprinting in clusters: lessons from Beckwith–Wiedemann syndrome. Trends Genet 1997;13:330–4.
Nicholls RD, Saitoh S, Horsthemke B. Imprinting in Prader–Willi and Angelman syndromes. Trends Genet 1998;14:194–200.
Hurst LD, McVean GT. Growth effects of uniparental distomes and the conflict theory of genomic imprinting. Trends Genet 1997;13:436–43.
Sotomaru Y, Kawase Y, Ueda T, et al Disruption of imprinted expression of U2afbp-rs/U2af1-rs1 gene in mouse parthenogenetic fetuses. J Biol Chem 2001;276:26694–8.
Poirier F, Chan CT, Timmons PM, Robertson EJ, Evans MJ, Rigby PW. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 1991;113:1105–14.
Han VKM, Carter AM. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 2000;21:289–305.
Pringle KG, Roberts CT. New light on early post-implantation pregnancy in the mouse: roles for insulin-like growth factor-II (IGF-II)? Placenta 2007;28:286–97.
Minniti CP, Luan D, O’Grady C, Rosenfeld RG, Oh Y, Helman LJ. Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype. Cell Growth Differ 1995;6:263–9.
Pacher M, Seewald MJ, Mikula M, et al. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells. Carcinogenesis 2007;28:49–59.
Prelle K, Wobus AM, Krebs O, et al. Overexpression of insulin-like growth factor-II in mouse embryonic stem cells promotes myogenic differentiation. Biochem Biophys Res Commun 2000;277:631–8.
Weber MM, Fottner C, Schmidt P, et al. Postnatal overexpression of insulin-like growth factor II in transgenic mice is associated with adrenocortical hyperplasia and enhanced steroidogenesis. Endocrinology 1999;140:1537–43.
Moorehead RA, Sanchez OH, Baldwin RM, Khokha R. Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma. Oncogene 2003;22:853–7.
Petrik J, Pell JM, Arany E, et al. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 1999;140:2353–63.
Newman-Smith E, Werb Z. Functional analysis of trophoblast giant cells in parthenogenetic mouse embryos. Dev Genet 1997;20:1–10.
Kawahara M, Wu Q, Takahashi N, et al. High-frequency generation of viable mice from engineered bi-maternal embryos. Nat Biotechnol 2007;25:1045–50.
Kono T, Kawahara M, Wu Q, et al. Paternal dual barrier by Ifg2-H19 and Dlk1-Gtl2 to parthenogenesis in mice. Ernst Schering Res Found Workshop 2006;23–33.
Sheehy E, Conrad SL, Brigham LE, Hiura H, Obata Y. Estimating the number of potential organ donors in the United States. N Engl J Med 2003;349;667–74.
Coombes JM, Trotter JF. Development of the allocation system for deceased donor liver transplantation. Clin Med Res 2005;3:87–92.
Nagy A, Gocza E, Diaz EM, et al. Embryonic stem cells alone are able to support fetal development in the mouse. Development 1990;110:815–21.
Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 1993;90:8424–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ragina, N., Cibelli, J. (2009). Parthenogenetic Embryonic Stem Cells in Nonhuman Primates. In: Baharvand, H. (eds) Trends in Stem Cell Biology and Technology. Humana Press. https://doi.org/10.1007/978-1-60327-905-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-60327-905-5_3
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-904-8
Online ISBN: 978-1-60327-905-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)